Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polycomb group RING finger protein 1 (PCGF1) is a key component of variant Polycomb Repressor Complex 1 (PRC1), a multiprotein assembly that establishes and maintains transcriptionally repressive chromatin states crucial for developmental gene regulation[1][2][3][4]. PCGF1 acts as a transcriptional repressor, helping to recruit PRC1-like complexes to target genes via interactions mediated by its RAWUL domain, notably forming complexes with BCOR and KDM2B, which contribute to gene silencing through histone H2A monoubiquitination and H3K36 demethylation[1][3][4]. Its biological functions implicate PCGF1 in embryonic development, maintenance of pluripotency, cell cycle control, and cancer progression by regulating genes such as BCL6 and CDKN1A[2][4]. Diseases associated with mutations or dysregulation of PCGF1 include developmental disorders and cancer, reflecting its pivotal role in gene expression and cellular homeostasis[2][3].
Recruitment and assembly of multiprotein PRC1-like complexes; Monoubiquitination of histone H2A leading to gene silencing; Interaction with co-repressors (e.g., BCOR, KDM2B)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycomb group RING finger protein 1 (PCGF1).